Investing.com’s stocks of the week
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Yorkville Ives on Meta Platforms Inc. (META): 'the Street is still underestimating its growth potential in our view'
October 26, 2026 8:42 AM EDTYorkville Ives analyst Dan Ives reiterated an Outperform rating and $920.00 price target on Meta Platforms Inc. (NASDAQ: META).
The analyst comments "The Street should not be surprised. The new Class C is a funding lever, and management said on the 3Q26 call that it adds financing flexibility while preserving voting control and that it had no specific plans yet; five days later it does. Meta generated $97 billion of operating cash flow through the first three quarters of 2026, but capex... More
Citi reiterates sell rating on Moderna with $80 price target
October 26, 2026 6:38 AM EDTCiti analyst Geoff Meacham reiterated a Sell rating and $80.00 price target on Moderna (NASDAQ: MRNA).
Meacham said Moderna's ESMO investor call focused on the potential of intismeran, with management and participating key opinion leaders emphasizing its neoantigen-specific immune response, efficacy across melanoma risk... More



